TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/11/2024
Back to search
Official data from USPTO
CORREGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
02/11/2024
Classification
Registered
Trademark type
Combined
Nice classes
5, 42
Filing date
02/17/2022
Registration date
08/08/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2023
Last transaction
02/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
CN
Examiner
GARCIA, CLAUDIA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Corregene Biotechnology Co., Ltd
Representatives
Robert J. Kenney Willcox & Savage, P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; biological preparations for medical purposes for the treatment of tumorscancerprecancerous lesionschronic infectionsautoimmune diseasesfatty liverinflammatory bowel diseasecervical neoplasiaviral infectionsmetabolic diseasesimmunodeficiencyosteoarthritisthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesallergicimmune disorderTORCH infections and immunoglobulin diseases; veterinary preparations for the prevention and treatment of intestinal bacteriacolibacillosissalmonellosispasteurellabrucellosisfoot-and-mouth diseasetuberculosisplagueinfectious diseasesinfluenzaimmune related diseases and nutrient deficiency related diseases; stem cells for veterinary purposes; preparations for destroying noxious animals
Class 42
product quality testing of pharmaceuticals; technical research in the field of pharmaceutical studies; research and development of drugs; medical and scientific researchconducting clinical trials for others; genomic structure and function analysis; genetic testing for scientific research; the testing of starting materialsintermediate products and end products of proteincell and gene therapy pharmaceutical products
Publications
History of USPTO decisions and trademark events.
30 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2023
FIMP
FINAL DISPOSITION PROCESSED
11/09/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/08/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/23/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/23/2023
PUBO
PUBLISHED FOR OPPOSITION
05/23/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/03/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/14/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/25/2023
RFNT
REFUSAL PROCESSED BY IB
11/15/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/21/2022
RFRR
REFUSAL PROCESSED BY MPU
10/21/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/31/2022
CNRT
NON-FINAL ACTION WRITTEN
08/30/2022
DOCK
ASSIGNED TO EXAMINER
08/25/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/05/2022
Continuous trademark protection
Get notified about every new filing that threatens CORREGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.